Now Open: Flemingsberg Science Award STARTUP 2026

Do you have a business idea that can make a difference, locally or globally? Flemingsberg Science Award STARTUP is the competition for those who want to challenge their idea, gain valuable feedback from experienced experts, and take the first step toward building something real. 

The competition is open to students, professionals, and residents of Flemingsberg and serves as a qualifying competition for the national business plan competition Venture Cup. In addition to the chance to win SEK 10,000, the winner will receive three months of membership at a co-working space, a dynamic meeting place at the heart of Campus Flemingsberg with proximity to academia, science and other entrepreneurs.  

Whether you have just started sketching out your idea or have already come a long way, this is your opportunity to test, develop, and grow. Your next step starts here. 

 

Deadline: September 15th 2026

Read more about Flemingsberg Science Award > 
Apply now > 

Download poster here

Portabel Health: Crowned Winner of Flemingsberg Science STARTUP Award 2025

Quickly finding the right personnel is one of the healthcare sector’s major challenges, especially in times of staff shortages and increasing demands for efficiency. Portabel Health offers a modern solution to these problems through a digital platform that makes it easy for care providers to access qualified nurses and healthcare professionals.

Press Start: The Game Hub in Flemingsberg – Finally!

On April 24th, after just two months of hard work, it was finally time for the kick-off for the game cluster Press Start. The initiative is led by Drivhuset, in close collaboration with Flemingsberg Science Foundation and Södertörn University's Innovation Station.

AlzeCure Pharma – a hope in the fight against Alzheimer’s

Neurological diseases and the pain area are struggling with great medical needs, including the lack of broad-spectrum drugs. Those are gaps in the market that AlzeCure Pharma wants to fill, and they are well on their way. They recently received a grant from the European Innovation Council (EIC) to finance a clinical phase 2 study of the drug candidate NeuroRestore ACD856 for Alzheimer’s disease.

Want to know more? Subscribe to our newsletter.

SUBSCRIBE
CF_logo_neg

Want to know more? Subscribe to our newsletter.

CF_logo_neg
Logo Row
CF logoBK logoHuddinge kommunKI logoKTH logoRegion StockholmRKH logoSödertörn logoSMI logoStockholm logo
fb yt insta
fb yt insta
Go to Top